ReviewJournal of cardiovascular development and disease2023

SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain.

Bartosz Rolek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.